Furthermore, the FoxM1 expression affected the tumorigenic ability of glioma cells in vitro and in vivo, including proliferation, migration and angiogenesis, which consistent with other studies [28]–[30]. This evidence concerns the gene FOXM1 and central nervous system cancer.